Tus kws kho mob
P83-17 Clarification to MHCP Prior Authorization Requirements for Nusinersen (Spinraza)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 13, 2017
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3141 - 3150 ntawm 3669
Tus kws kho mob
P37-18 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial Members - eviCore Healthcare Utilization Management (UM) Program
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 04, 2018
Tus kws kho mob
2018 April Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 02, 2018
Tus kws kho mob
P36-17 Addition of Drug to the Vesicular Monoamine Transporter 2 Inhibitors (VMAT2) Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 13, 2017
Tus kws kho mob
P66-18 eviCore Healthcare Specialty Utilization Management for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P20-18 2018 Renewal Changes Summary For Blue Plus Referral Health Professional Providers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P38-17 New Drug-Related Prior Authorization (PA) for Xolair
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 05, 2017
Tus kws kho mob
P28-18 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2018
Tus kws kho mob
P27-18 New Site of Care Drug Management Program for Infused and Injectable Drugs Administered by a Health Care Provider
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 02, 2018
Tus kws kho mob
P71-17 Prenatal Health Assessment (H1000) Denial for PMAP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 15, 2017